造影剤の市場規模、シェア、成長分析：種類別、形態別、モダリティ別、投与経路別、適応症別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

造影剤市場規模は2023年に69億米ドルと評価され、2024年の74億6,000万米ドルから2032年には139億1,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは8.1％で成長する見通しです。

造影剤市場は現在、慢性疾患の有病率の上昇、画像技術の進歩、画像診断手技の増加などの影響を受けています。しかし、特にアレルギー反応などの安全性への懸念や、造影剤に関連する高コストが成長の妨げとなっており、発展途上地域での導入が制限される可能性があります。このような課題にもかかわらず、市場は造影剤開発における技術革新、技術統合の強化、新興国市場の拡大に牽引され、着実な成長が見込まれています。このような動向は、利害関係者にとって、安全性と価格の問題に対処しつつ、進歩を利用し、増大する需要に対応する機会を提供するものです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析

造影剤市場規模：種類別

• 市場概要
• ヨウ素化造影剤
• ガドリニウムベース造影剤
• マイクロバブル造影剤
• バリウム系造影剤

造影剤市場規模：形態別

• 市場概要
• 液体
• 粉
• その他の形式

造影剤市場規模：モダリティ別

• 市場概要
• X線
• コンピュータ断層撮影（CT）
• 磁気共鳴画像法（MRI）
• 超音波

造影剤市場規模：投与経路別

• 市場概要
• 血管内経路
• 経口投与
• 直腸経路
• その他の投与経路

造影剤市場規模：適応症別

• 市場概要
• 心血管疾患
• がん
• 胃腸障害
• 筋骨格系障害
• 神経疾患
• 腎臓疾患

造影剤市場規模：用途別

• 市場概要
• 放射線科
• インターベンショナルラジオロジー
• インターベンショナルカーディオロジー

造影剤市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Bayer AG（Germany）
• GE Healthcare（USA）
• Bracco Imaging S.p.A.（Italy）
• Guerbet（France）
• Lantheus Holdings, Inc.（USA）
• Merck KGaA（Germany）
• FUJIFILM Corporation（Japan）
• Taejoon Pharm Co., Ltd.（South Korea）
• Beijing Beilu Pharmaceutical Co., Ltd.（China）
• Nano Therapeutics Pvt. Ltd.（India）
• CMC Contrast AB（Sweden）
• Imax Diagnostic Imaging（Canada）
• Trivitron Healthcare（India）
• Fresenius Kabi（Germany）
• Sanochemia Pharmazeutika AG（Austria）
• J.B. Chemicals & Pharmaceuticals Ltd.（India）
• Jodas Expoim Pvt. Ltd.（India）
• Livealth Biopharma（China）
• Spago Nanomedical AB（Sweden）
• Subhra Pharma Pvt. Ltd.（India）

結論と提言

Contrast Media Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 7.46 billion in 2024 to USD 13.91 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The contrast media market is currently influenced by a rising prevalence of chronic diseases, advances in imaging technologies, and an increase in diagnostic imaging procedures. However, growth is hindered by safety concerns, particularly regarding allergic reactions, and the high costs associated with contrast agents, which can limit adoption in developing regions. Despite these challenges, the market is expected to experience steady growth driven by innovations in contrast agent development, enhanced technological integration, and expanding markets. These trends present opportunities for stakeholders to capitalize on advancements and cater to growing demand while addressing safety and affordability issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Media Market Segments Analysis

Global Contrast Media Market is segmented by Type, Form, Modality, Route of Administration, Indication, Application and region. Based on Type, the market is segmented into Iodinated contrast media, Gadolinium-based contrast media, Microbubble contrast media and Barium-based contrast media. Based on Form, the market is segmented into Liquid, Powder and Other forms. Based on Modality, the market is segmented into X-ray, Computed tomography (CT), Magnetic resonance imaging (MRI) and Ultrasound. Based on Route of Administration, the market is segmented into Intravascular route, Oral route, Rectal route and Other routes of administration. Based on Indication, the market is segmented into Cardiovascular disease, Cancer, Gastrointestinal disorders, Musculoskeletal disorders, Neurological disorders and Nephrological disorders. Based on Application, the market is segmented into Radiology, Interventional radiology, Interventional cardiology. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Media Market

The Contrast Media market is primarily driven by an increasing awareness among patients about the critical role of diagnostic imaging in managing and detecting diseases, leading to a heightened demand for contrast agents. Additionally, the advocacy from healthcare professionals significantly contributes to market growth, as medical practitioners are increasingly acknowledging the value and benefits of contrast-enhanced imaging in achieving accurate diagnoses and outcomes. This recognition has translated into a surge in the number of prescriptions for these agents, further fuelling the expansion of the Contrast Media market as both patients and providers seek to enhance diagnostic effectiveness.

Restraints in the Contrast Media Market

The growth of the Contrast Media market is significantly hindered in many developing regions due to a limited number of healthcare professionals and inadequate access to advanced technologies and facilities. Furthermore, the lack of awareness about the benefits and applications of contrast media can impede market expansion. Additionally, insufficient training for medical practitioners regarding the use of contrast agents and their associated imaging techniques further restricts adoption. These factors collectively contribute to a challenging environment for the growth of the contrast media market, as they prevent effective utilization and understanding of these critical imaging tools within the healthcare sector.

Market Trends of the Contrast Media Market

The Contrast Media market is witnessing a significant trend towards improved safety profiles, driven by advancements in gadolinium-based contrast agents. Research focusing on minimizing nephrogenic systemic fibrosis (NSF) risks has led to the development of novel agents that emphasize reduced gadolinium retention. This shift is pushing healthcare providers to favor agents with enhanced safety features, which are particularly beneficial for patients with compromised renal function. Additionally, the adoption of non-ionic low osmolar contrast agents in computed tomography is gaining traction, as they effectively minimize side effects. This evolving landscape highlights a growing preference for safer, more effective contrast media solutions among healthcare professionals.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Contrast Media Market Size by Type & CAGR (2025-2032)

• Market Overview
• Iodinated contrast media
• Gadolinium-based contrast media
• Microbubble contrast media
• Barium-based contrast media

Global Contrast Media Market Size by Form & CAGR (2025-2032)

• Market Overview
• Liquid
• Powder
• Other forms

Global Contrast Media Market Size by Modality & CAGR (2025-2032)

• Market Overview
• X-ray
• Computed tomography (CT)
• Magnetic resonance imaging (MRI)
• Ultrasound

Global Contrast Media Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intravascular route
• Oral route
• Rectal route
• Other routes of administration

Global Contrast Media Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Cardiovascular disease
• Cancer
• Gastrointestinal disorders
• Musculoskeletal disorders
• Neurological disorders
• Nephrological disorders

Global Contrast Media Market Size by Application & CAGR (2025-2032)

• Market Overview
• Radiology
• Interventional radiology
• Interventional cardiology

Global Contrast Media Market Size & CAGR (2025-2032)

• North America (Type, Form, Modality, Route of Administration, Indication, Application)
  • US
  • Canada
• Europe (Type, Form, Modality, Route of Administration, Indication, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Form, Modality, Route of Administration, Indication, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Form, Modality, Route of Administration, Indication, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Form, Modality, Route of Administration, Indication, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taejoon Pharm Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Beilu Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Therapeutics Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMC Contrast AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imax Diagnostic Imaging (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanochemia Pharmazeutika AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.B. Chemicals & Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jodas Expoim Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livealth Biopharma (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spago Nanomedical AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Subhra Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations